Stryker Corporation SYK

272.36 2.61 0.97% as of 25 Sep
Market cap
$103.9B
P/E
28.0×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

Stryker Corporation (SYK) EV/Sales

As of 25 September 2026, Stryker Corporation (SYK) trades at a EV/Sales of 4.5×. Over the past ten years it has ranged from 3.3× (January 2016) to 7.6× (April 2021); the current reading is higher than 17% of that period. That is above the Medical Devices industry median of 2.4× and above the Healthcare sector median of 3.6×.

EV/Sales, daily

Annual

Period EV/Sales Change
FY2025 5.8× (10.16%)
FY2024 6.5× 8.43%
FY2023 6.0× 5.75%
FY2022 5.6× (12.41%)
FY2021 6.4× (10.17%)
FY2020 7.2× 25.38%
FY2019 5.7× 20.12%
FY2018 4.8× (6.61%)
FY2017 5.1× 19.84%
FY2016 4.3× 21.24%

Quarterly

Period EV/Sales Change
Jun 2026 5.1× (6.01%)
Mar 2026 5.4× (6.40%)
Dec 2025 5.8× (8.28%)
Sep 2025 6.3× (8.64%)
42 more quarters

Against its own ten years

Low 3.3× High 7.6×
Ten-year median 5.6×
Current reading's percentile 17

EV/Sales against peers

Company EV/Sales
PHG Koninklijke Philips N.V. compare 1.4×
GEHC GE HealthCare Technologies Inc. compare 1.9×
MDT Medtronic PLC compare 3.5×
STE STERIS plc compare 3.6×
BSX Boston Scientific Corporation compare 3.7×
ABT Abbott Laboratories compare 4.4×
SYK Stryker Corporation 4.5×
DXCM DexCom, Inc. compare 6.5×
EW Edwards Lifesciences Corporation compare 7.1×
Medical Devices industry median 2.4×
Healthcare sector median 3.6×
Market median 2.2×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on SYK